Results: In the derivation study, five predictive factors (presence/absence of hypertension, estimated glomerular filtration rate, maximum intima-media thickness [max-IMT], ankle-brachial index [ABI], and use/nonuse of diabetic medication) were used to develop a prediction formula. In the validation study, positive predictive value (PPV) and negative predictive value (NPV) of the cutoff value derived from the prediction formula were 53% and 73%, respectively.
1.

Introduction
The incidence of type 2 diabetes mellitus (DM) is increasing worldwide [1] . Approximately one-third of all patients with type 2 DM live in Western Pacific countries, including Japan. The prevalence of type 2 DM in this region was reported to be 8.6% in 2013, and the number of patients with diabetic complications is increasing. Therefore, appropriate treatment of the disease and prevention of its complications are vital. Diabetic complications are largely divided into microvascular and macrovascular complications. Studies such as the Kumamoto Study [2] and the United Kingdom Prospective Diabetes Study 33 (UKPDS 33) [3] demonstrated that intensive glycemic control prevents microvascular complications. However, another study reported that silent myocardial ischemia occurred in 22-39% of patients with type 2 DM who already had an autonomic disorder as a complication [4] .
Currently classical risk factors for ischemic heart disease, which is a major macro vascular complication of type 2 DM, include smoking, dyslipidemia, hypertension, type 2 DM, family history of heart disease, age, and sex [5] [6] [7] [8] . Myocardial infarction is the most serious macrovascular complication of type 2 DM. Type 2 DM was shown to be a risk factor for developing myocardial infarction in the Framingham Study [9] and the UKPDS 35 [10] . However, the classical risk factors alone do not sufficiently predict the occurrence of coronary artery disease [11, 12] ; therefore, direct evaluation of the condition of the coronary artery is important in type 2 DM patients.
Multi-detector computed tomography (MDCT) is an important instrument for detecting coronary artery stenosis. Recent advances in MDCT allow non-invasive and rapid evaluation of the coronary artery. With the development of this technology, the accuracy of diagnosing coronary artery stenosis has improved. A study investigating the accuracy of 64-slice MDCT in assessing coronary artery stenosis reported that the overall sensitivity, specificity, positive predictive value, and negative predictive value for classifying stenosis were 94%, 97%, 87%, and 99%, respectively [13] . Coronary computed tomography angiography (CCTA) is a specialized method for evaluating the coronary artery in MDCT. However, CCTA is not recommended for the screening of coronary artery disease in every patient with type 2 DM because it requires radiation exposure and contrast agents.
The purpose of this study was to develop a model for predicting significant coronary artery stenosis in patients with type 2 DM by examining the association between coronary artery stenosis as assessed by CCTA and background risk factors. The cohort was divided into two groups; one cohort was used for a derivation study and the second cohort was used for a validation study. A prediction model was developed using the data from the first cohort, and the validation was performed using the data from the second cohort. In addition, we compared the ability of the developed model to predict coronary artery stenosis using subject data applied to the UKPDS risk engine score, which estimated 10-year non-fatal coronary heart disease risk.
2.
Material and methods
Subjects
All subjects were Japanese patients with type 2 DM who underwent CCTA at Jinnouchi Hospital from June 2007 to September 2011. We considered subjects eligible when they fulfilled the following criteria: age 40 years or older at the time of enrollment and diagnosis of type 2 DM by diabetologists based on the Japan Diabetes Society's criteria [14] . Based on these initial eligibility criteria, study subjects needed to meet at least one of these additional metrics for CCTA: (1) type 2 DM duration of P10 years, (2) HbA1c of at least P7%, (3) body mass index (BMI) of P25 kg/m 2 , and/or (4) history of smoking and of having dyslipidemia. Study subjects underwent CCTA regardless of symptoms or signs. We omitted patients from the study with missing data prior to study entry. Patients were divided into derivation and validation cohorts (Fig. 1) . The derivation cohort comprised 327 patients who underwent CCTA from June 2007 to December 2009, and the validation cohort comprised 317 patients who underwent CCTA from January 2010 to September 2011. Significant coronary artery stenosis was defined as the presence of at least one stenotic lesion with P50% coronary artery obstruction. The exclusion criteria were (1) renal insufficiency, (2) contrast allergy, (3) revascularization, (4) asthma, and (5) cardiac arrhythmias. Patients with severe coronary calcification were excluded due to the associated difficulty in evaluating the coronary lumen. Severe coronary calcification was defined as the lumen not being able to be described by short-axis view. The study protocol was approved by Jinnouchi Hospital's committees on the ethics of human research. All subjects enrolled in this study provided written informed consent.
2.2.
Assessment of coronary artery disease by CCTA CCTA was performed with a 64-slice MDCT scanner (LightSpeed VCT, GE Medical Systems, Waukesha, Wisconsin, USA) with 64 Â 0.625-mm section collimation, a 350 or 400-ms rotation time, a 120-kV tube voltage, and a pitch from 0.16 to 0.18 depending on the patient's heart rate. The estimated mean radiation dose was 15-18 mSv. A non-contrast scan was initially performed to determine anatomical landmarks for the contrast-enhanced study. Immediately thereafter, test bolus tracking with 10 mL of a non-ionic contrast agent was applied to calculate the exact arrival time of the contrast agent in the coronary arteries, with a region of interest in the proximal part of the ascending aorta. Finally, a contrast-enhanced scan with retrospective electrocardiogram gating was performed after administration of the contrast medium (220 mg I/kg body weight/10 s) during a single breath hold. Image reconstruction was performed using image analysis software (CardIQ, GE Healthcare) on a dedicated computer workstation (Advantage Workstation Ver. 4.2, GE Healthcare). A standard kernel was used as the reconstruction filter. Depending on the patient's heart rate, either a half-scan or multi-segment reconstruction algorithm was selected or the optimal cardiac phase with the fewest motion artifacts was chosen. MDCT was performed with betablockers and sublingual nitrates if necessary. Patients with at least one stenotic lesion with P50% obstruction of the coronary artery were considered to have significant coronary artery stenosis. All CCTA images were evaluated by a radiologist and a radiological technologist. Atherosclerotic lesions were classified visually as obstructive (P50% luminal narrowing) or non-obstructive (<50% luminal narrowing).
Ankle-brachial index and pulse wave velocity measurement
The ankle-brachial index (ABI) and brachial artery pulse wave velocity (baPWV) were assessed using the automatic device form PWV/ABI (BP-203PRE; Colin, Japan). Patients were placed in the supine position for at least 5 min, and systolic blood pressures of the brachial artery of each arm and the posterior tibial arteries of each ankle were measured using a Doppler probe. The highest blood pressure in the arms was used to calculate the ABI. The ratio of ankle-to-arm systolic blood pressure was calculated for each leg, and the lowest ratio was recorded as the ABI for the patient. To measure baPWV, pulse waves obtained from the brachial and tibial arteries were recorded simultaneously, and transmission time, which was defined as the time interval between the initial increase in brachial and tibial waveforms, was determined. The transmission distance from the arm to each ankle was calculated based on the patient's height. The baPWV value was automatically computed as the transmission distance divided by the transmission time. After obtaining bilateral baPWV values, the higher value was used as the representative value for each subject. Measurements obtained using form PWV/ABI have been shown to have good reproducibility [15] . For our study, we assessed intra-observer reproducibility in our institutes by Bland-Altman analysis, which was performed in 28 consecutive subjects. The 95% CI of the mean difference of two measurements included zero (CI: À0.011 to 0.001).
Intima-media thickness
B-mode ultrasonography of the carotid artery was performed using an ultrasound machine (SDU-1200, Shimazdu, Japan) paired with a 7.5-MHz multi-frequency high-resolution linear transducer. The near and far walls of the right and left common carotid arteries (CCAs) (at least 1.5 cm proximal to the origin of the carotid bulb [CB] , bifurcations at the CB) and proximal internal carotid arteries (ICAs) were scanned. The carotid intima-media thickness (IMT) was measured in the posterior wall of the carotid artery as the distance between the leading edge of the first and second echogenic lines. The thickest points for the IMT (including plaque lesions) in the CCA, ICA, and CB were recorded, and the highest value among them was defined as the maximum IMT (max-IMT). Reproducibility analysis of replicate measurements in 20 subjects yielded absolute mean ± SD differences of 0.02 ± 0.01, 0.01 ± 0.01, 0.02 ± 0.01, and 0.01 ± 0.01 mm for mean-IMT-CCA, max-IMT-CCA, max-IMT-Bulb, and max-IMT-ICA, respectively.
Laboratory analysis
For analysis of serum concentrations of total cholesterol, triglycerides (TG), creatine, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and hemoglobin A1c (HbA1c), blood samples were collected in the morning after an overnight fast while the patient was in a seated position. Dyslipidemia was defined as LDL-C P3.4 mmol/L, HDL-C <1.1 mmol/L, TG P1.7 mmol/L, or current use of a lipid-lowering agent. Hypertension was defined as systolic blood pressure (SBP) P140 mmHg, diastolic blood pressure (DBP) P90 mmHg, or current use of an antihypertensive agent. Smoking status was categorically defined on the basis of self-reports. Estimated glomerular filtration rate (eGFR) was determined by the modified Modification of Diet and Renal Disease study formula (MDED) for Japanese 
individuals: eGFR = 194 Â (age
) Â (0.739 if female) [16] . The HbA1c level was converted from the Japanese Diabetes Society value into the National Glycohemoglobin Standardization Program (NGSP) equivalent value [17] .
Calculation of the UKPDS risk engine
We calculated the UKPDS risk engine score for individual subjects and evaluated its predictive ability for coronary artery stenosis by receiver-operating characteristic (ROC) curve analyses as the UKPDS risk engine is an established type 2 diabetes-specific risk calculator for cardiovascular disease. The UKPDS risk engine was downloaded from the UKPDS website [18] .
Statistical analysis
All values are reported as the means ± standard deviations, median and interquartile range, or as the number of subjects with percentages in parentheses. Between-group differences of the average were compared using the unpaired t test for parametric data, and the Mann-Whitney U test was used for nonparametric data. The Spearman rank coefficient was used to assess the correlation between coronary stenosis and patient characteristics for parametric data, and the Pearson's correlation coefficient for nonparametric data. Multivariate logistic regression analysis was used to detect independent predictors of coronary stenosis. The ability of our regression model to predict coronary stenosis was examined by ROC curve analyses. We used the z test to calculate the statistical significance of the different areas under the curve (AUC) between our regression model and the UKPDS risk engine. Statistical analysis was performed using SPSS Statistics version 20.0 software (IBM Corporation, Armonk, New York, USA), and C-statistical analyses were performed with EZR (Saitama Medical Center, Jichi Medical University, Saitama, Japan). For all tests, a p-value <0.05 was considered statistically significant.
Results
Patient characteristics and medications are shown in Table 1 .
The participants in the derivation study were 327 patients with type 2 DM, consisting of 198 men and 129 women, with a mean age of 68.3 ± 8.9 years, a mean duration of diabetes of 14.8 ± 9.7 years, and a mean HbA1c level of 7.5 ± 1.5% (57 ± 13 mmol/mol). Overall, 61% of the derivation cohort had significant coronary artery stenosis. Clinical variables were compared between those with and without coronary artery stenosis using the Mann-Whitney U test. Significant differences were observed in diabetes duration, SBP, HDL-C, eGFR, ABI, hypertension, max-IMT, carotid plaque occurrence, and use of diabetic medication and insulin treatment (Table 1) . We observed no significant difference between men and women in the prevalence of coronary artery disease in this cohort. Logistic regression analysis showed that the significant factors associated with coronary artery stenosis were hypertension, eGFR, max-IMT, ABI, and use of diabetic medication ( Table 2 ). The regression formula was Y = 2.84 + 0.55 Â hypertension À 0.02 Â eGFR + 0.41 Â maxIMT À 0.24 Â ABI + 0.84 Â diabetic medication. The optimal cut-off point for the regression model was 0.17 (sensitivity, 67%; specificity, 63%). The validity of the cut-off point was tested in a subgroup of 313 patients with type 2 DM ( Table 3 ).
The assessment revealed true-positive results in 70 patients and true-negative results in 136 patients; additionally, there were 68 false-positive and 43 false-negative cases. The values for sensitivity, specificity, PPV, and NPV were 62%, 67%, 53%, and 73%, respectively. A comparison of the predictive ability of our model and the UKPDS risk engine showed that the areas under the curve (AUCs) in the ROC analysis were 0.70 (95% confidence interval [CI], 0.64-0.76) for our model, 0.62 (95% CI, 0.56-0.69) for the UKPDS risk engine, and 0.66 (95% CI, 0.59-0.72) for the UKPDS risk engine + max-IMT. The AUC for our model was significantly better than that for the UKPDS risk engine (p = 0.03) and the UKPDS risk engine + max-IMT (p = 0.02) (Fig. 2) . The value of SBP and DBP are the means ± standard deviations. Other values are median (interquartile range) or n (%). P value compared with diabetes patients with and without coronary stenosis by unpaired t test, Mann-Whitney U test.
4.
Discussion
For the purposes of this research, we performed a multivariate analysis to investigate the potential association between coronary artery stenosis as assessed by CCTA in patients with type 2 DM and background risk factors. We found that hypertension, eGFR, max-IMT, ABI, and diabetic medication use were independent predictive factors for coronary artery stenosis. We further evaluated the validity of the cut-off point for the prediction model and found that the PPV and NPV were 53% and 73%, respectively. In addition, the accuracy of our model for predicting coronary artery stenosis was better than that of the UKPDS risk engine (AUC, 0.70 vs. 0.62, p = 0.03). Silent myocardial ischemia was reported to occur during stress testing in 22% of the patients with type 2 DM who had no chest symptoms, suggesting a high prevalence of coronary artery disease in patients with type 2 DM [4] . Patients with 50% or greater stenosis of the left main coronary artery or those with 75% or greater stenosis of the other coronary arteries on coronary CT are recommended to undergo percutaneous coronary intervention [19] . Patients without type 2 DM with 50% or greater stenosis had a 10-fold greater risk of developing acute myocardial infarction than patients with less than 50% stenosis [20] . Based on these findings, we reasoned that predicting 50% or greater stenosis of the coronary artery in patients with type 2 DM would be useful for the early detection of high-risk patients and early pharmacological intervention, which can prevent cardiovascular events. In this study, therefore, we performed an analysis by dividing patients into a stenosis group (those with 50% or more obstruction) and a non-stenosis group (those with less than 50% stenosis) based on CCTA results.
Among the five predictive factors identified in the derivation study, hypertension has frequently been reported to be a risk factor of ischemic heart disease and to be associated with coronary artery stenosis [21] . Chronic kidney disease (CKD) and decreased eGFR or positive urine protein are more highly associated with coronary artery stenosis than normal kidney function, and CKD severity is associated with coronary artery stenosis severity [22] . Max-IMT, an index of arterial sclerosis, is greater in patients with type 2 DM with coronary artery stenosis [23] . In accordance with these findings, the present study showed that these factors are independent predictors of coronary artery stenosis.
Interestingly, we found the prevalence of coronary artery stenosis to be quite different between the derivation group (60%) and the validation group (35%). We have determined that such a difference might be based on the need to perform CCTA clinically according to eligibility criteria. It might cause this decrease of the prevalence in the latter period. Validation of our model against the UKPDS risk engine clearly shows this discrepancy, as there is a significant difference between the derivation study (28 [10.4-39.5] ) and validation study (23 [13.9-35.7] ). In both cohorts, we found that hypertension, eGFR, max-IMT, ABI, and diabetic medication use were independent predictive factors for coronary artery stenosis.
Some researchers have reported that patients with coronary artery stenosis, including individuals without type 2 DM, had decreased ABIs [24, 25] . However, no previous studies have reported the use of ABI as a risk factor in a predictive formula for coronary artery stenosis in patients with type 2 DM. Our study showed that ABI, which is determined by a noninvasive and low-cost test and has clinical significance in detecting coronary artery stenosis, is a predictor of coronary artery stenosis in patients both with and without type 2 DM.
It is noteworthy that we found diabetic medication use to be a predictor of coronary artery stenosis. A recent study reported that patients with acute myocardial infarction and type 2 DM had more advanced coronary artery disease than those without type 2 DM [26] . The reason for this finding may be that diabetic patients are prone to arteriosclerosis, even in the early stages of the disease, and are likely to have advanced coronary disease when they start taking medication to help manage their diabetes. It is known that patients with type 2 DM and obesity are prone to coronary artery stenosis, even in the early stage of type 2 DM [27] . It is also known that patients with a longer duration of type 2 DM have more advanced coronary artery stenosis than those with a shorter disease duration [28] . However, BMI and type 2 DM duration were not significant predictive factors in our logistic regression analysis. A comparison of the two variables between patients with and without diabetic medication use showed significant differences; specifically, BMI was greater in those taking diabetic medications (24.4 ± 4.2 kg/m 2 vs. 23.0 ± 3.1 kg/m 2 , p = 0.04), and the duration of diabetes was longer in those taking diabetic medications (15.5 ± 9.5 years vs. 9.3 ± 9.2 years, p < 0.01). We speculate that the differences in these background characteristics may influence the association between diabetic medication use and coronary artery stenosis.
A recent study showed that an additional assessment of HbA1c values provided little incremental benefit in predicting cardiovascular event risk [29] . In the present study, HbA1c was not a predictive factor for coronary artery stenosis, which may be attributable to a limitation of the HbA1c measurement at the time of CT examination. We considered that a single HbA1c measurement might not have been sufficient to evaluate the effect of type 2 DM on coronary artery stenosis.
The results of the validation analysis showed a high NPV; the PPV and NPV were 53% and 73%, respectively. We suggest that patients should undergo CCTA only when the presence of coronary artery stenosis cannot be ruled out by the regression model, allowing efficient screening for coronary artery stenosis. Although the UKPDS risk engine is useful in predicting coronary artery disease in patients with type 2 DM, our regression model is more accurate in predicting coronary artery stenosis. The regression model, involving indices of arteriosclerosis (i.e., max-IMT and ABI), allows the prediction of coronary artery stenosis based not only on lifestyle habits and biochemistry but also on clinical parameters reflecting vessel condition.
In addition, our prediction formula was consistent with not only max-IMT (evaluation of macrovascular complications) but also ABI (evaluation of peripheral artery disease). A key difference between our study and previous research [30] is that our study predicted over 50% coronary stenosis as well as whether patients required revascularization. It is known that strict LDL treatment leads to the regression of coronary artery plaque of [31] . Performing CCTA enables clinicians to evaluate coronary artery plaque at its presumably earliest stages, and, if plaque is observed, the clinical team can begin a strict medication regimen as needed. In turn, this can lead to a slowing of the progression coronary stenosis and associated cardiovascular events.
Recently, some controversies are discussed for clinical significance of coronary revascularization therapy in the type 2 DM patients with severe but asymptomatic coronary artery disease. In the BARI2D study, the results showed the intensive and optimal medical therapy was useful for asymptomatic coronary artery disease in type 2 DM patients to be adapted for revascularization [32] . We have now recognized that the limited utility of coronary angiography to identify severe coronary artery disease in patients with type 2 DM. The intensive and optimal medical therapies should be provided to all type 2 DM patients. However, in the practical clinical situation, it is really difficult to achieve the optimal medical therapies with multiple drug combination use, and lifestyle intervention. We think that it must be important to recognize the high-risk condition with the presence of coronary plaques more than 50% stenosis for both patients and physicians in the clinical situation. CCTA can give us the clear visual information of coronary plaque burden and we can non-invasively identify type 2 DM patients with moderate lesion stenosis (>50%) in coronary arteries. We here demonstrated the useful risk stratification strategy with non-invasive atherosclerotic evaluation tests by IMT-measurement and ABI. Based on these clinical information, we consider that the patients and physicians can fully understand the atherosclerotic disease condition and the physician can extensively provide the effective optimal medical therapies for type 2 DM patients.
It is clear that CT is essential for evaluating coronary artery lesions. With advances in CT technology, delineation time and radiation dose have been significantly reduced. However, it is unrealistic to perform CCTA on every patient for the purpose of screening for coronary artery disease. We believe that the regression model developed in the present study is clinically useful for coronary artery disease screening, particularly for those patients with type 2 DM for whom CCTA is contraindicated or in situations in which patients are being treated in clinical settings without CCTA equipment.
Limitations
Our study has some limitations. One is that the calcification score was not evaluated. A recent study reported that higher calcification scores as measured by CCTA were associated with higher mortality due to cardiovascular events in patients with type 2 DM and that the addition of the calcification score to the set of Framingham risk factors significantly improved the prediction of cardiovascular death [33] . We did not include the calcification score in the study design because our primary objective was to develop a model to guide decisionmaking on whether CCTA should be performed. The other limitation of our study is that this model was tested in a relatively small number of Japanese patients. Further studies are needed to generalize our findings to other races or ethnic groups.
Conclusions
Our results showed that a regression model using five factors that are feasibly obtained in clinical practice could predict the presence of coronary artery stenosis in patients with type 2 DM. These factors are hypertension, eGFR, max-IMT, ABI (both noninvasive measurements of arteriosclerosis), and diabetic medication (hypoglycemic drug or insulin) use. The early detection of coronary artery stenosis enables the initiation of earlier intervention of strictly medication for hypertension and dyslipidemia, leading to an improved prognosis in patients with type 2 DM at high risk for cardiovascular events.
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